Open original FDA record ↗Recall record
- FDA identifier
- Z-0825-2012
- Company in FDA record
- Fresenius Medical Care Holdings, Inc.
- FDA classification date
- Jan 20, 2012
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Optiflux F250NRe Hemodialyzers have increased risk of an internal blood leak
Source facts
- Action
- Fresenius Medical Care North America contacted customers by telephone on December 27, 2011, and sent a Customer Notification letter dated December 27, 2011, via certified mail return receipts and fax - back requested to all affected customers. Customers were instructed to examine your stock of dialyzers, and isolate and discontinue use of the before mentioned lots. If you have identified dialyzers from the recalled lots, please contact Customer Service for a Return Goods Authorization. We will pick up the product you currently have in stock and supply replacement product. All products for return will be picked up during your next scheduled Fresenius delivery. Promtly fill out the fax-back reply form attached to the notification. Please do not return used dialyzers. For further questions, please call 1 (800) 662-1237.
- Initiated
- 2011-12-27
- Root cause
- Process control
- Terminated
- 2013-07-08
- Distribution
- Worldwide Distribution -- USA (nationwide) and the country of Canada.
- Recall number
- Z-0825-2012
- Recall status
- Terminated
- CDRH record ID
- 106328
- FDA classified
- 2012-01-20
- Recall event number
- 60734